Proteome Sciences plc (PMSNF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.62 Million USD | -203.85% |
| 2022 | 1.8 Million USD | 160.36% |
| 2021 | 692.12 Thousand USD | -3.74% |
| 2020 | 719.01 Thousand USD | 94.54% |
| 2019 | 369.6 Thousand USD | 121.23% |
| 2018 | -1.74 Million GBP | 28.34% |
| 2017 | -2.42 Million GBP | 26.5% |
| 2016 | -3.3 Million GBP | 27.56% |
| 2015 | -4.56 Million GBP | -14.28% |
| 2014 | -3.99 Million GBP | -18.4% |
| 2013 | -3.37 Million GBP | 20.48% |
| 2012 | -4.24 Million GBP | 2.31% |
| 2011 | -4.34 Million GBP | -189.07% |
| 2010 | 4.87 Million GBP | 226.07% |
| 2009 | -3.86 Million GBP | 9.65% |
| 2008 | -4.27 Million GBP | 17.28% |
| 2007 | -5.17 Million GBP | 14.01% |
| 2006 | -6.01 Million GBP | 9.41% |
| 2005 | -6.64 Million GBP | -30.22% |
| 2004 | -5.1 Million GBP | 25.89% |
| 2003 | -6.88 Million GBP | -63.94% |
| 2002 | -4.19 Million GBP | -106.9% |
| 2001 | -2.02 Million GBP | -67.96% |
| 2000 | -1.2 Million GBP | 3.82% |
| 1999 | -1.25 Million GBP | 37.26% |
| 1998 | -2 Million GBP | -19.31% |
| 1997 | -1.67 Million GBP | -2.88% |
| 1996 | -1.63 Million GBP | 0.0% |
| 1994 | -24 Thousand GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -2.15 Million USD | 0.0% |
| 2023 Q2 | -206.89 Thousand USD | 0.0% |
| 2023 FY | -1.87 Million USD | -203.85% |
| 2023 Q4 | -1.85 Million USD | 0.0% |
| 2022 FY | 1.8 Million USD | 160.36% |
| 2022 Q2 | 324.96 Thousand USD | 0.0% |
| 2022 Q4 | 1.76 Million USD | 0.0% |
| 2021 FY | 692.12 Thousand USD | -3.74% |
| 2021 Q2 | -377.13 Thousand USD | 0.0% |
| 2021 Q4 | 919.22 Thousand USD | 0.0% |
| 2020 Q4 | 1.16 Million USD | 0.0% |
| 2020 FY | 719.01 Thousand USD | 94.54% |
| 2020 Q2 | -423.81 Thousand USD | 0.0% |
| 2019 Q4 | 715.36 Thousand USD | 0.0% |
| 2019 FY | 369.6 Thousand USD | 121.23% |
| 2019 Q2 | -334.72 Thousand USD | 0.0% |
| 2018 FY | -1.74 Million GBP | 28.34% |
| 2017 FY | -2.42 Million GBP | 26.5% |
| 2016 FY | -3.3 Million GBP | 27.56% |
| 2015 FY | -4.56 Million GBP | -14.28% |
| 2014 FY | -3.99 Million GBP | -18.4% |
| 2013 FY | -3.37 Million GBP | 20.48% |
| 2012 FY | -4.24 Million GBP | 2.31% |
| 2011 FY | -4.34 Million GBP | -189.07% |
| 2010 FY | 4.87 Million GBP | 226.07% |
| 2009 FY | -3.86 Million GBP | 9.65% |
| 2008 FY | -4.27 Million GBP | 17.28% |
| 2007 FY | -5.17 Million GBP | 14.01% |
| 2006 FY | -6.01 Million GBP | 9.41% |
| 2005 FY | -6.64 Million GBP | -30.22% |
| 2004 FY | -5.1 Million GBP | 25.89% |
| 2003 FY | -6.88 Million GBP | -63.94% |
| 2002 FY | -4.19 Million GBP | -106.9% |
| 2001 FY | -2.02 Million GBP | -67.96% |
| 2000 FY | -1.2 Million GBP | 3.82% |
| 1999 FY | -1.25 Million GBP | 37.26% |
| 1998 FY | -2 Million GBP | -19.31% |
| 1997 FY | -1.67 Million GBP | -2.88% |
| 1996 FY | -1.63 Million GBP | 0.0% |
| 1994 FY | -24 Thousand GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -30.515% |
| Arrayit Corporation | -3.62 Million USD | 55.252% |
| Atlantic International Corp. | -5.73 Million USD | 71.723% |
| Biocept, Inc. | -31.98 Million USD | 94.932% |
| Bioqual, Inc. | -19.63 Thousand USD | -8154.405% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -109.935% |
| DermTech, Inc. | -103.73 Million USD | 98.437% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.065% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 92.218% |
| iMD Companies, Inc. | -175.44 Thousand USD | -823.931% |
| IDenta Corp. | -1499.00 USD | -108038.759% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 157.81% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 4289.713% |
| InVitro International | -25.33 Thousand USD | -6297.253% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 77.24% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -2689.441% |
| Medical Imaging Corp. | -819.48 Thousand USD | -97.808% |
| NovelStem International Corp. | -3.52 Million USD | 54.025% |
| Optigenex Inc. | 1.39 Million USD | 216.549% |
| PharmChem, Inc. | 973.14 Thousand USD | 266.573% |
| Response Genetics, Inc | -21.37 Million USD | 92.417% |
| Rennova Health, Inc. | -1.4 Million USD | -15.003% |
| RushNet, Inc. | -684.7 Thousand USD | -136.744% |
| ScreenPro Security Inc. | -2.59 Million USD | 37.472% |
| Stella Diagnostics Inc. | -11.42 Million USD | 85.814% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 79.075% |
| Todos Medical Ltd. | -9.74 Million USD | 83.371% |